The unmet needs in the erectile dysfunction market

20%

ED impacts around 20% of
men globally across all age brackets1

50%

Approximately half of all men over 40 experience ED2

25%

Around 25% of new diagnoses are in men under 403

Prior to Eroxon®, existing treatments for ED were available only on prescription in most countries around the world, creating barriers to access5. Embarrassment, denial, reticence, cost of a consultation and lack of awareness may prevent someone seeking the help of a doctor or healthcare practitioner. Men with ED whose sexual partners wish to be supportive and solutions-oriented are doubly hindered by these factors as up until the launch of Eroxon® only the sufferer could be prescribed the treatment. Oral treatments can also have systemic side effects and cannot be taken in combination with several medications.

Eroxon® and its new formulation Eroxon® Intense offers a different approach. As a fast-acting, topical treatment available over the counter, Eroxon® can be used in the moment and integrated into intimacy, including as part of foreplay. This enables a more natural, less medical experience that supports both partners. Positioned as a first-step, particularly for men with mild to moderate or occasional ED, Eroxon® occupies a distinct space in the category - bridging efficacy, spontaneity, and a more experience-led approach to sexual health.

50%

Approximately half of all men with ED do not discuss their condition with their doctor6

  1. EMA, Withdrawal assessment report for Viagra, 2008
  2. Feldman HA et al. J Urol 1994; 151: 54 – 61
  3. Pozzi, J of Sexual Medicine, Volume 20, 2022
  4. Manufacturer’s Selling Prices, IQVIA market data, 2023
  5. In the UK, Ireland, Norway, Poland, New Zealand, and Switzerland, sildenafil 50mg can be purchased without prescription but still requires the involvement of the pharmacist. Cialis 10mg has recently switched OTC in the UK and also requires involvement of the pharmacist
  6. Jannini et al – Health-related characteristics and unmet needs of men with erectile dysfunction: a survey in five European countries, J Sex Med, 2014 Jan.